Jan 10, 2019 - Investors could be well served by ETFs and stocks from top-ranked sectors.
Jan 03, 2019 - Although VIVUS (VVUS) is struggling with its legacy products, promotional initiatives and addition of cash-flow positive assets bode well for the company.
Jan 03, 2019 - Teva (TEVA) ends an ongoing patent dispute with Amgen over generic Sensipar by making an undisclosed payment.
Dec 28, 2018 - The stability in the industry sets the stage for players to get back on growth track. Here we discuss three stocks picks from the industry.
Nov 19, 2018 - Johnson & Johnson's (J&J) apalutamide gets positive CHMP opinion for the treatment of adult patients with non-metastatic castration-resistant prostate cancer.
Oct 09, 2018 - Strong growth in the Indian economy should aid stocks from this region.
Oct 02, 2018 - Dr. Reddy's (RDY) divests its Bristol, TN-based antibiotic manufacturing site and related assets to an Abu Dhabi-based company.
Sep 07, 2018 - Revlimid is Celgene's biggest moneymaker by far. But here's how and why CEO Mark Alles wants to make it disappear.
Jul 25, 2018 - Smart Beta ETF report for BICK
May 23, 2018 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q4 2018 Earnings Conference Call May 22, 2018 09:00 AM ET Executives Saunak Savla - Investor Relations G.V. Prasad - Chief Executive Officer Erez Israeli -